Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

'Corrigendum to "2017 Taiwan lipid guidelines for high risk patients" [Journal of the Formosan Medical Association (2017) [217-248]'.

Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients.

J Formos Med Assoc. 2018 Aug;117(8):749-750. doi: 10.1016/j.jfma.2018.07.007. No abstract available.

2.

In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.

Chen KC, Yin WH, Wu CC, Chan SH, Wu YW, Yang Wang K, Chang KC, Hwang JJ, Voon WC, Hsieh IC, Chong JT, Lin WS, Hsu CN, Ueng KC, Hsia CP, Liu JC, Yeh JS, Mar GY, Shih JY, Kuo JY, Tsao HM, Tseng WK, Yang CH, Chang CC, Chiang CE, Lei MH, Lin JF, Shyu KG.

Acta Cardiol Sin. 2018 May;34(3):211-223. doi: 10.6515/ACS.201805_34(3).20180207B.

3.

2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.

Chiang CE, Lin SY, Lin TH, Wang TD, Yeh HI, Chen JF, Tsai CT, Hung YJ, Li YH, Liu PY, Chang KC, Wang KL, Chao TH, Shyu KG, Yang WS, Ueng KC, Chu PH, Yin WH, Wu YW, Cheng HM, Shin SJ, Huang CN, Chuang LM, Lin SJ, Yeh SJ, Sheu WH, Lin JL.

J Chin Med Assoc. 2018 Mar;81(3):189-222. doi: 10.1016/j.jcma.2018.01.001. Epub 2018 Feb 13.

4.

CHA2 DS2 -VASc scores for outcome prediction in acute ischaemic stroke.

Su CH, Tsao TF, Chen AC, Chang KW, Yang YS, Ueng KC, Tsai CF.

Eur J Clin Invest. 2018 Mar;48(3). doi: 10.1111/eci.12884. Epub 2018 Jan 29.

PMID:
29288496
5.

Bacterial alterations in salivary microbiota and their association in oral cancer.

Lee WH, Chen HM, Yang SF, Liang C, Peng CY, Lin FM, Tsai LL, Wu BC, Hsin CH, Chuang CY, Yang T, Yang TL, Ho SY, Chen WL, Ueng KC, Huang HD, Huang CN, Jong YJ.

Sci Rep. 2017 Nov 28;7(1):16540. doi: 10.1038/s41598-017-16418-x.

6.

The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension.

Chiang CE, Wang TD, Lin TH, Yeh HI, Liu PY, Cheng HM, Chao TH, Chen CH, Shyu KG, Ueng KC, Chen CY, Chu PH, Sung SH, Wang KL, Li YH, Wang KY, Chiang FT, Lai WT, Chen JH, Chen WJ, Yeh SJ, Chen MF, Lin SJ, Lin JL.

Acta Cardiol Sin. 2017 May;33(3):213-225. Review.

7.

Prehospital Predictors of Initial Shockable Rhythm in Out-of-Hospital Cardiac Arrest: Findings From the Taichung Sudden Unexpected Death Registry (THUNDER).

Lin YN, Chang SS, Wang LM, Chi HT, Ueng KC, Tsai CF, Phan CS, Lu LH, Hii CH, Chung YT, Chugh SS, Chen MF, Wu TJ, Chang KC.

Mayo Clin Proc. 2017 Mar;92(3):347-359. doi: 10.1016/j.mayocp.2016.10.029.

PMID:
28259227
8.

2017 Taiwan lipid guidelines for high risk patients.

Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients.

J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. Review. Erratum in: J Formos Med Assoc. 2018 Aug;117(8):749-750.

9.

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.

Chiang CE, Wu TJ, Ueng KC, Chao TF, Chang KC, Wang CC, Lin YJ, Yin WH, Kuo JY, Lin WS, Tsai CT, Liu YB, Lee KT, Lin LJ, Lin LY, Wang KL, Chen YJ, Chen MC, Cheng CC, Wen MS, Chen WJ, Chen JH, Lai WT, Chiou CW, Lin JL, Yeh SJ, Chen SA.

J Formos Med Assoc. 2016 Nov;115(11):893-952. doi: 10.1016/j.jfma.2016.10.005. Epub 2016 Nov 24.

10.

Relationship of Genetic Polymorphisms of Aldosterone Synthase Gene Cytochrome P450 11B2 and Mineralocorticoid Receptors with Coronary Artery Disease in Taiwan.

Chou CH, Ueng KC, Yang SF, Wu CH, Wang PH.

Int J Med Sci. 2016 Feb 1;13(2):117-23. doi: 10.7150/ijms.13862. eCollection 2016.

11.

Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation.

Tsai CT, Hsieh CS, Chang SN, Chuang EY, Ueng KC, Tsai CF, Lin TH, Wu CK, Lee JK, Lin LY, Wang YC, Yu CC, Lai LP, Tseng CD, Hwang JJ, Chiang FT, Lin JL.

Nat Commun. 2016 Feb 2;7:10190. doi: 10.1038/ncomms10190.

12.

Molybdenum induces pancreatic β-cell dysfunction and apoptosis via interdependent of JNK and AMPK activation-regulated mitochondria-dependent and ER stress-triggered pathways.

Yang TY, Yen CC, Lee KI, Su CC, Yang CY, Wu CC, Hsieh SS, Ueng KC, Huang CF.

Toxicol Appl Pharmacol. 2016 Mar 1;294:54-64. doi: 10.1016/j.taap.2016.01.013. Epub 2016 Jan 21.

PMID:
26806093
13.

Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan.

Ting KH, Ueng KC, Chiang WL, Chou YE, Yang SF, Wang PH.

Evid Based Complement Alternat Med. 2015;2015:851683. doi: 10.1155/2015/851683. Epub 2015 Nov 24.

14.

Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study.

Yang TY, Liaw YP, Huang JY, Chang HR, Chang KW, Ueng KC.

Acta Diabetol. 2016 Jun;53(3):461-8. doi: 10.1007/s00592-015-0817-x. Epub 2015 Dec 21.

PMID:
26687195
15.

Impact of Intercellular Adhesion Molecule-1 Genetic Polymorphisms on Coronary Artery Disease Susceptibility in Taiwanese Subjects.

Chou CH, Ueng KC, Liu YF, Wu CH, Yang SF, Wang PH.

Int J Med Sci. 2015 Jun 9;12(6):510-6. doi: 10.7150/ijms.12097. eCollection 2015.

16.

Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.

Ho LT, Yin WH, Chuang SY, Tseng WK, Wu YW, Hsieh IC, Lin TH, Li YH, Huang LC, Wang KY, Ueng KC, Fang CC, Pan WH, Yeh HI, Wu CC, Chen JW; Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry Investigators.

PLoS One. 2015 Mar 10;10(3):e0116513. doi: 10.1371/journal.pone.0116513. eCollection 2015.

17.

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.

Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.

Vasc Health Risk Manag. 2015 Jan 21;11:71-8. doi: 10.2147/VHRM.S76599. eCollection 2015.

18.

Association of Serum Uric Acid with Cardiovascular Disease in Taiwanese Patients with Primary Hypertension.

Yang TY, Fang CY, Chen JS, Po HL, Chou LP, Chiang CY, Ueng KC.

Acta Cardiol Sin. 2015 Jan;31(1):42-51.

19.

2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.

Chiang CE, Wang TD, Ueng KC, Lin TH, Yeh HI, Chen CY, Wu YJ, Tsai WC, Chao TH, Chen CH, Chu PH, Chao CL, Liu PY, Sung SH, Cheng HM, Wang KL, Li YH, Chiang FT, Chen JH, Chen WJ, Yeh SJ, Lin SJ.

J Chin Med Assoc. 2015 Jan;78(1):1-47. doi: 10.1016/j.jcma.2014.11.005. Epub 2014 Dec 26.

20.

Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial.

Yang YS, Su YF, Yang HW, Lee YH, Chou JI, Ueng KC.

Phytother Res. 2014 Dec;28(12):1770-7. doi: 10.1002/ptr.5197. Epub 2014 Aug 6.

PMID:
25131839

Supplemental Content

Loading ...
Support Center